Lipid and macromolecules quantitation in differentiating glioblastoma from solitary metastasis: A short-echo time single-voxel magnetic resonance spectroscopy study at 3 T

Journal of Computer Assisted Tomography

Volumn 37, Issue 2, 2013, Pages 265-271

  Crisi, Girolamo ^a   Orsingher, Laura ^a   Filice, Silvano ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

Absolute quantitation; Glioblastoma; Lipid and macromolecules; Magnetic resonance spectroscopy; Metastasis

Indexed keywords

BRAIN; MACROMOLECULES; MAGNETIC RESONANCE IMAGING; MAGNETISM; MOLECULAR BIOLOGY; PATHOLOGY; RESONANCE; TUMORS;

ABSOLUTE QUANTITATION; BRAIN METASTASIS; BRAIN TUMORS; CELLULARS; ECHO TIME; GLIOBLASTOMAS; LIPID AND MACROMOLECULE; METASTASIS; PROSPECTIVE STUDY; SINGLE VOXEL;

MAGNETIC RESONANCE SPECTROSCOPY;

LIPID;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BRAIN METASTASIS; CANCER CLASSIFICATION; CANCER SIZE; CANCER SURGERY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; FEMALE; GLIOBLASTOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; MACROMOLECULE; MALE; MOLECULAR BIOLOGY; NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO;

EID: 84875428057     PISSN: 03638715     EISSN: 15323145     Source Type: Journal    
DOI: 10.1097/RCT.0b013e318282d2ba     Document Type: Article

References (48)

1. Patchell RA, Tibbs PA,Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990; 322:494-500
2. Nussbaum ES, Djalilian HR, Cho KH, et al. Brain metastases. Histology, multiplicity, surgery, and survival. Cancer. 1996;78: 1781-1788
3. Campos S, Davey P, Hird A, et al. Brain metastasis from an unknown primary, or primary brain tumor? A diagnostic dilemma. Curr Oncol. 2009;16:62-66
4. Devos A, Lukas L, Suykens JA, et al. Classification of brain tumors using short echo time 1H MR spectra. J Magn Reson. 2004;170: 164-175
5. Tate AR, Griffiths JR, Martinez-Perez I, et al. Towards a method for automated classification of 1H MRS spectra from brain tumours. NMR Biomed. 1998;11:177-191
6. Ishimaru H, Morikawa M, Iwanaga S, et al. Differentiation between high-grade glioma and metastatic brain tumor using single-voxel proton MR spectroscopy. Eur Radiol. 2001;11:1784-1791
7. Howe FA, Barton SJ, Cudlip SA, et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med. 2003;49:223-232
8. Opstad KS, Murphy MM, Wilkins PR, et al. Differentiation of metastases from high-grade gliomas using short echo time 1H spectroscopy. J Magn Reson Imaging. 2004;20:187-192
9. Sjøbakk TE, Johansen R, Bathen TF, et al. Metaboling profiling of human brain metastases using in vivo proton MR spectroscopy at 3T. BMC Cancer. 2007;7:141-151
10. Kuesel AC, Sutherland GR, Halliday W, et al. 1HMRS of high grade astrocytomas: Mobile lipid accumulation in necrotic tissue. NMR Biomed. 1994;7:149-155
11. Glunde K, Artemov D, Penet MF, et al. Magnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancer. Chem Rev. 2010;110:3043-3059
12. Chawla S, Zhang Y, Wang S, et al. Proton magnetic resonance spectroscopy in differentiating glioblastomas from primary cerebral lymphomas and brain metastases. J Comput Assist Tomogr. 2010;34: 836-841
13. Server A, Josefsen R, Kulle B, et al. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors. Acta Radiologica. 2010;51:316-325
14. Law M, Cha S, Knopp EA, et al. High grade gliomas and solitary metastases: Differentiation by using perfusion and proton spectroscopic MR imaging. Radiology. 2002;222:715-721
15. Server A, Orheim TE, Graff BA, et al. Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility contrastenhanced perfusion MR Imaging in the differentiation of glioblastoma multiforme and brain metastasis. Neuroradiology. 2011;53:319-330
16. Cha S, Lupo JM, Chen MH, et al. Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR Imaging. AJNR Am J Neuroradiol. 2007;28:1078-1084
17. Tate AR, Underwood J, Acosta DM, et al. Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra. NMR Biomed. 2006;19: 411-434
18. García-Gómez JM, Luts J, Julià-Sapé M, et al. Multiproject-multicenter evaluation of automatic brain tumor classification by magnetic resonance spectroscopy. MAGMA. 2009;22:5-18
19. Webb PG, Sailasuta N, Kohler SJ, et al. Automated single-voxel proton MRS: Technical development and multisite verification. Magn Reson Med. 1994;31:365-373
20. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993;30:672-679
21. Kovanlikaya A, Panigrahy A, Krieger MD, et al. Untreated pediatric primitive neuroectodermal tumor in vivo: Quantitation of taurine with MR spectroscopy. Radiology. 2005;236:1020-1025
22. Kiricuta IC, Simplaceanu V. Tissue water content and nuclear magnetic resonance in normal and tumor tissue. Cancer Res. 1975;35: 1164-1167
23. Cheng LL, Chang IW, Louis DN, et al. Correlation of high resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. Cancer Res. 1998;58:1825-1832
24. Jansen JF, Backes WH, Nicolay K, et al. 1HMR spectroscopy of the brain: Absolute quantification of metabolites. Radiology. 2006;240: 318-332
25. Daumas-Duport C, Scheithauer B, O'Fallon J, et al. Grading of astrocytomas. A simple and reproducible method. Cancer. 1988;62: 2152-2165
26. Auer DP, Gössl C, Schirmer T, et al. Improved lipid analysis of 1H-MR spectra in the presence of mobile lipids. Magn Reson Med. 2001;46: 615-618
27. Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: A multicenter study. J Neurosurg. 1996;84:449-458
28. Murphy PS, Rowland J, Viviers L, et al. Could assessment of glioma methylene lipid resonance by in vivo 1H-MRS be of clinical value? Br J Radiol. 2003;76:459-463
29. Zoula S, Rijken PFJW, Peters JPW, et al. Pimonidazole binding in C6 rat brain glioma: Relation with lipid droplet detection. Br J Cancer. 2003;88:1439-1444
30. Stegh AH, Chin L, Louis DN, et al. What drives intense apoptosis resistance and propensity for necrosis in glioblastomäCell Cycle. 2008;7:2833-2839
31. Callies R, Sri-Pathmanathan RM, Ferguson DY, et al. The appearance of neutral lipid signals in the 1H NMR spectra of a myeloma cell line correlates with the induced formation of cytoplasmic lipid droplets. Magn Reson Med. 1993;29:546-550
32. Gillies RJ, Morse DL. In vivo magnetic resonance spectroscopy in cancer. Annu Rev Biomed Eng. 2005;7:287-326
33. Hakumaki JM, Kauppinen RA. 1H NMR visible lipids in the life and death of cells. Trends Biochem Sci. 2000;25:357-362
34. Lukas L, Devos A, Suykens JA, et al. Brain tumor classification based on long echo proton MRS signals. Artif Intell Med. 2004;31:73-89
35. Mountford CE, Wright LC, Holmes KT, et al. High resolution proton magnetic resonance analysis for metastatic cancer cells. Science. 1984;226:1415-1418
36. Ramadan S, Andronesi OC, Stanwell P, et al. Use of in vivo two-dimensional MR spectroscopy to comapre the biochemistry of the human brain to that of glioblastoma. Radiology. 2011;259:540-549
37. Derappe C, Bauvy C, Lemonnier M, et al. Determination of the structure of a fucose-containing trisaccharide monophosphate isolated from human pregnancy urine. Carbohydr Res. 1986;150:273-284
38. Listinsky JJ, Listinsky CM, Siegal GP. >-L-fucose in histology: A part of the cancer glycome hiding in plain sight. J Cytol Histol. 2012;3:102
39. Wang X, Gu J, Ihara H, et al. Core fucosylation regulates epidermal growth factor receptorYmediated intracellular signaling. J Biol Chem. 2006;281:2572-2577
40. Lean CL, Mackinnon WB, Delikatny EJ, et al. Cell-surface fucosylation and magnetic resonance spectroscopy characterization of human malignant colorectal cells. Biochemistry. 1992;31: 11095-11105
41. Adjei AA. Blocking oncogenic ras signaling for cancer therapy. J Natl Cancer Inst. 2001;93:1062-1074
42. Slebos RJ, Kibbelaar RE, Dalesio O, et al. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med. 1990;323:561-565
43. VanderMeulen DL, Prasad VV, Moskal Jr. The identification of glioblastoma-Associated, fucose-containing glycoproteins induced by retinoic acid. Mol Chem Neuropathol. 1994;21:311-327
44. Lefranc F, Brotchi J, Kiss R. Possible future issues in the treatment of glioblastomas: Special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol. 2005;23:2411-2422
45. Wenk MR. The emerging field of lipidomics. Nat Rev Drug Discov. 2005;4:594-610
46. Opstad KS, Bell BA, Griffiths JR, et al. An investigation of human brain tumour lipids by high-resolution magic angle spinning 1H MRS and histological analysis. NMR Biomed. 2008;21:677-685
47. Rosi A, Luciani AM, Matarrese P, et al. 1H-MRS lipid signal modulation and morphological and ultrastructural changes related to tumor cell proliferation. Magn Res Med. 1999;42:248-257
48. Chiang IC, Kuo YT, Lu CY, et al. Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings. Neuroradiology. 2004;46:619-627